ELADYNOS Trademark

Trademark Overview


On Friday, April 29, 2022, a trademark application was filed for ELADYNOS with the United States Patent and Trademark Office. The USPTO has given the ELADYNOS trademark a serial number of 97388239. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, August 5, 2024. This trademark is owned by Radius Health, Inc.. The ELADYNOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-re...
eladynos

General Information


Serial Number97388239
Word MarkELADYNOS
Filing DateFriday, April 29, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, August 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-related disorders and conditions; Pharmaceutical preparations to treat wounds and trauma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRadius Health, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Party NameRadius Health, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events


Event DateEvent Description
Monday, November 7, 2022ASSIGNED TO EXAMINER
Wednesday, November 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 3, 2022NEW APPLICATION ENTERED
Wednesday, May 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 1, 2024SOU EXTENSION 2 FILED
Thursday, February 1, 2024SOU EXTENSION 2 GRANTED
Sunday, July 30, 2023SOU TEAS EXTENSION RECEIVED
Sunday, July 30, 2023SOU EXTENSION 1 FILED
Sunday, July 30, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024SOU EXTENSION 3 FILED
Monday, August 5, 2024SOU EXTENSION 3 GRANTED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED